Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : Indonesia prepares more ICU units, waits to see if COVID curbs will be extended

07/24/2021 | 11:28pm EDT

JAKARTA, July 25 (Reuters) - Indonesia is preparing more intensive care units after logging several days of record-high COVID-19 deaths last week, while the country waits to see whether the government will extend or loosen tough restrictions due to expire on Sunday.

Buckling under a Delta variant-driven wave of the virus, Indonesia has become Asia's COVID-19 epicentre with hospitals deluged, particularly on the densely populated island of Java.

"Deaths have risen due to a number of factors: full hospitals, patients admitted with low saturation, or dying unmonitored in self-isolation," Senior Minister Luhut Pandjaitan said in a statement late on Saturday.

Luhut, who oversees the COVID response on the islands of Java and Bali, said ICU capacities would be added in areas that have reported the highest fatalities.

Bali, famous for its tourist beaches and temples, has been grappling with oxygen shortages.

Indonesia last week reported record-high deaths on four separate days, the last of which was Friday's 1,566 fatalities, bringing cumulative deaths to more than 82,000. Total case infections have climbed to over 3.1 million, though health experts say both deaths and case numbers have been undercounted.

Just under 7% of its population of 270 million has been fully vaccinated, with Southeast Asia's largest country primarily reliant on shots produced by China's Sinovac Biotech .

The debate over whether to loosen restrictions has pitted health experts, who say it is premature to ease curbs during a surge of infections, against employer groups that have warned of mass layoffs unless the curbs are relaxed.

The government is due to hold a news conference later on Sunday but has not set a time. (Reporting by Stanley Widianto and Bernadette Christina; Additional reporting by Tabita Diela; Editing by Edwina Gibbs)


ę Reuters 2021
All news about SINOVAC BIOTECH LTD.
09/22SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November
RE
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
09/09SINOVAC BIOTECH : Says its New Research Shows Third Dose if its COVID-19 Vaccine More Effe..
MT
09/09SINOVAC BIOTECH : New Research on SINOVAC's COVID-19 Vaccine Shows Third Dose More Effecti..
BU
09/08SINOVAC BIOTECH : Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Child..
BU
09/07SINOVAC BIOTECH : Mixing CanSinoBIO, Sinovac COVID shots induces stronger response than Si..
RE
09/01SINOVAC BIOTECH : North Korea turns down Sinovac COVID-19 vaccine doses - WSJ
RE
08/24SINOVAC BIOTECH : COVID-19 booster shots should follow after China inoculates more -state ..
RE
08/23São Paulo City Will Require Proof of Vaccination to Enter Shops, Bars
DJ
08/19SINOVAC BIOTECH : U.N. facility allocates 3 mil. doses of China's vaccine to N. Korea
AQ
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,5%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED10.53%103 374
WUXI BIOLOGICS (CAYMAN) INC.17.22%66 169
SAMSUNG BIOLOGICS CO.,LTD.11.38%52 198
BIOGEN INC.18.16%43 118
ALEXION PHARMACEUTICALS, INC.0.00%40 336